| Date Posted |
Subject |
| Dec. 30, 2006 |
Are facilities routinely performing platelet sterility QC with the BacT/ALERT® system using both aerobic and anaerobic culture bottles? |
| Dec. 24, 2006 |
REACTIVATED DISCUSSION: Stability of ADAMTS13 in thawed cryoprecipitate poor plasma (CPP) stored for more than 24 hours Apr. 27, 2005; ADDENDA Apr. 27, 2005; Dec. 24, 2006 |
| Dec. 22, 2006 |
Checking plasma fibrinogen levels for patients undergoing a series of Therapeutic Plasma Exchange (TPE) procedures using 5% albumin as replacement fluid |
| Dec. 16, 2006 |
Have any transfusion services received requests for washed blood products for pediatric and neonatal patients receiving live virus vaccines? ADDENDA Dec. 19, 22 & 23, 2006 |
| Dec. 16, 2006 |
REACTIVATED DISCUSSION: Relabeling thawed FFP as thawed plasma ADDENDA Mar. 5, 2002; Dec. 16 & 21, 2006 |
| Dec. 6, 2006 |
How do laboratories label test tubes that are used in manual tube tests, to assure 'traceability' and compliance with AABB Standard 5.1.6.2? ADDENDA Dec. 8, 16 & 26 |
| Dec. 5, 2006 |
What audit/tracking systems do trauma centers use to assess the adequacy of transfusion support for emergent and massive transfusion events in their facility ADDENDA Dec. 16 & 19; June 27, 2007 |
| Nov. 30, 2006 |
Do facilities plan to request an exception to allow 5 day storage of pooled platelets? |
| Nov. 20, 2006 |
Do blood collection centers defer donors, either whole blood or apheresis, who are taking an ACE-inhibitor, regardless of the diagnosis? ADDENDA Nov. 21 |
| Nov. 20, 2006 |
How are hospitals that use 5% albumin as a replacement fluid for some therapeutic plasma exchange procedures addressing a lack of supply of that solution? Do colleagues consider the use of plasma protein fraction to be a safe alternative? ADDENDA Nov. 22; Aug. 21 & 29, 2008 |
| Nov. 20, 2006 |
Is there any regulation or accreditation requirement for the temperature at which a blood product should be cultured, when the blood product is considered as a possible cause of an adverse reaction due to suspected bacterial contamination? ADDENDA Nov. 26 & 27 |
| Nov. 15, 2006 |
REACTIVATED DISCUSSION: What do blood collection centers do with donors who are implicated in TRALI, and those whose blood is at high risk of causing TRALI? Jan. 7, 2004; ADDENDA July 30, 2004; June 3, 2005; Nov. 15, 2006 |
| Nov. 13, 2006 |
Should stricter physical exam criteria be used for qualifying prospective blood donors over 60 years of age? |
| Nov. 12, 2006 |
REACTIVATED DISCUSSION: Preventing pre-transfusion specimen labeling errors Jan. 30, 2002; ADDENDA Jan 30 & 31, Feb. 3, 2002; June 20, 21 & Nov. 12, 2006 |
| Nov. 12, 2006 |
REACTIVATED DISCUSSION: What forms of proof of identity are required of prospective blood donors? June 30, 2003; ADDENDA July 1, 3 & 5; Nov. 12, 2006 |
| Nov. 9, 2006 |
REACTIVATED DISCUSSION: What
is the correct procedure for decommissioning
an outdated blood product irradiator? Nov. 21, 2005; ADDENDA Nov.
23 & Jan. 22 & Aug. 4 & 31; Nov. 9 & 13, Dec. 8, 2006;
June 22 & 27, July 11, 2007 |
| Nov. 7, 2006 |
Is "reinjection" of radiolabeled white cells by a nuclear medicine department considered a transfusion, and if so, does the transfusion service track or regulate this procedure? ADDENDA Nov. 8 |
| Nov. 2, 2006 |
REACTIVATED DISCUSSION: Indications for and use of the 'Biological Crossmatch' Aug. 10, 2004; ADDENDA Aug. 11, 12, 16 & 17, Sept. 22; Nov. 2, 2006 |
| Oct. 30, 2006 |
Published guidelines and standardized use of fibrin sealants and topical hemostatic agents ADDENDA Oct. 31, 2006 |
| Oct. 26, 2006 |
How do Trauma Facilities limit use of uncrossmatched trauma blood? |
| Oct. 16, 2006 |
Management of other components from a donation when red cells fail leukocyte reduction filtration |
| Oct. 16, 2006 |
Management of donor registration forms found to be incomplete or lacking donor's signature following donation ADDENDA Oct. 16, 18 & 26 |
| Oct. 9, 2006 |
Use of 'canned text comments' in transfusion reaction and antibody identification pathology reports ADDENDA Oct. 16, Nov. 1, 7 & 8 |
| Oct. 9, 2006 |
REACTIVATED DISCUSSION: Should blood banks store autologous bone flaps in their freezer? July 19, 2001; ADDENDA July 22, Aug. 1 & Dec. 17, 2001; Oct. 9 & 13, 2006 |
| Oct. 3, 2006 |
The serological and/or clinical significance of indicating "strong" or "weak" notations when grading antigen-antibody reactions ADDENDA Oct. 4 |
| Sept. 21, 2006 |
REACTIVATED DISCUSSION: Should pre-transfusion ABO/Rh testing be performed twice, and if so, on different samples or by different personnel? Dec. 5, 2002; ADDENDA Dec. 6, 9, 10, 12 & 20; Jan. 8 & 9, 2003; July 20, 26, 28, Aug. 3, 10, 15, 24 & 26, 2004; Dec 28 & 31, 2004; Jan 24, May 3, 4, 8, 10, 11 & 14, 2005; Sept. 21 & 29, 2006 |
| Sept. 15, 2006 |
How do blood collection centers manage underweight (under collected) or overweight (over-collected) whole blood units? ADDENDA Sept. 18, Oct. 19 |
| Sept. 12, 2006 |
REACTIVATED DISCUSSION: What is an effective strategy to assure that a blood product dispensed via a pneumatic tube system is administered to the correct recipient? Mar. 28, 2005; ADDENDA Sept. 12 & 18, 2006; Feb. 26, 2007 |
| Sept. 12, 2006 |
A question about managing a hospital's blood product inventory when the hospital's laboratory does NOT perform any pretransfusion testing on site |
| Sept. 6, 2006 |
The use of saline washed RBCs versus premedications for patients with Sickle Cell Disease and occasional mild to moderate urticarial reactions. Should we treat the patient or treat the blood? ADDENDA Sept. 12 |
| Sept. 5, 2006 |
How do Blood Donor Collection Centers (including hospital sites) manage donor consent for incompetent adults who present as prospective blood donors? ADDENDA Sept. 12 & 28 |
| Aug. 29, 2006 |
REACTIVATED DISCUSSION: Collecting allogeneic units from donors with hemochromatosis? Oct. 19, 2000; ADDENDA Oct. 29, Nov. 2, 9 and 10; Aug. 29 & Sept. 1, 2006 |
| Aug. 24, 2006 |
Selection of Rh-positive RBC units for brain-dead Rh-negative individuals who are scheduled for organ harvest |
| Aug. 18, 2006 |
Under what circumstances can an individual be reinstated as a prospective blood donor after being deferred for acknowledging that the reason they wanted to donate blood was to get an HIV test? ADDENDA Aug. 24 |
| Aug. 9, 2006 |
REACTIVATED DISCUSSION: Quality control of automated blood pressure cuffs used to evaluate blood donors Apr. 1, 2004; ADDENDA Aug. 4, 2006 |
| Aug. 4, 2006 |
Comprehensive standardized nursing protocol for manual exchange transfusion ADDENDA Sept. 4, 2006 |
| Aug. 4, 2006 |
Management and ensuring compliance of "tissue banking/tissue dispensing services" ADDENDA Aug. 9 |
| Aug. 3, 2006 |
The medical necessity of continuing to perform crossmatches on RBC units for patients who have experienced massive transfusion of at least 8-10 RBCs in less than 24 hours ADDENDA Aug. 7 |
| Aug. 3, 2006 |
Documentation of lot numbers for supplies used in the collection of blood products |
| Aug. 3, 2006 |
REACTIVATED DISCUSSION: Pneumatic Tube Systems for Transporting Blood? Jan. 9, 2000; ADDENDA Aug. 3, 2006 |
| Aug. 3, 2006 |
REACTIVATED DISCUSSION: Policies on the management of hearsay information received about otherwise qualified blood donors May 30, 2004; ADDENDA June 3 & 4; Aug. 3, 2006 |
| July 22, 2006 |
The use of medical alert bracelets for patients with clinically significant antibodies |
| July 22, 2006 |
Marked changes in red cell antibody titers during continuous veno-venous hemodialysis ADDENDA Aug 7 |
| July 12, 2006 |
Provision of irradiated fresh frozen plasma ADDENDA July 18 & 28 |
| July 7, 2006 |
REACTIVATED DISCUSSION: Procedures to minimize errors in selection of blood products for transfusion to ABO/Rh mismatched bone marrow transplant recipients Oct. 3, 2003; ADDENDA Oct. 6 & 10, Dec. 15; June 13, 15 & 16, 2004; July 7, 2006 |
| June 28, 2006 |
Should donors be deferred due to low WBC counts after automated Platelets, Pheresis collections? ADDENDA June 29, 2006 |
| June 22, 2006 |
What is the experience with using pretransfusion blood samples that are routinely used for up to 10 days (or longer) after their collection? ADDENDA June 24, 26 & 29 |
| June 21, 2006 |
Handling of Donor Recalls/Withdrawals for a diagnosis of CJD in a family member ADDENDA June 22 |
| June 16, 2006 |
REACTIVATED DISCUSSION: How
do blood banks know when a patient should get
irradiated blood, if the patient's doctor forgets
to order the blood to be irradiated?
Feb. 27, 2005; ADDENDA Feb. 28; Mar.
1, 7 & 8, 2005; Apr. 17, 19, 21 & 23; May 25; June 16, 2006;
Dec. 29, 2007 |
| June 16, 2006 |
A case of possible 'auto'anti-D during pregnancy? |
| June 14, 2006 |
How do collection centers or hospital blood banks manage post donation information events involving a diagnosis of cancer when the cancer diagnosis is made AFTER one or more previous blood donations? ADDENDA June 16, 2006 & May 21, 2007 |
| June 8, 2006 |
REACTIVATED DISCUSSION: Informing patients when pre-transfusion testing shows that their blood contains red cell antibodies April 28, 2002; ADDENDA April 29; June 8, 9, 12 & 16, 2006 |
| June 7, 2006 |
REACTIVATED DISCUSSION: Is
there a regional or national computerized
database of patients with multiple red cell antibodies or other
complex transfusion histories? Jan. 31, 2003; ADDENDA Feb.
5, 2003; Apr. 19, 20, 26 & May 5, 2004; Nov. 16 & 20, 2005;
June 7, 8, 9 & 12, 2006; Mar. 18, 2008 |
| June 6, 2006 |
Selection of donor RBCs for a patient with auto anti-e, but who is E-negative and e-positive ADDENDA June 6, 7, 8, 12 & 20 |
| June 5, 2006 |
Managing repeat blood donors who have adverse donor reactions on multiple occasions ADDENDA June 11 & 19 |
| June 4, 2006 |
REACTIVATED DISCUSSION: Infusing drugs or IV solutions along with blood May 16, 2002; ADDENDA May 17, 20, 21, 22 & 23, 2002; Dec. 30, 2005; June 4, 2006 |
| June 4, 2006 |
REACTIVATED DISCUSSION: Which solutions other than isotonic saline are approved for addition to blood and components? ADDENDA Feb. 4, 2001; June 4, 2006 |
| May 25, 2006 |
Is it compliant for a hospital transfusion service to operate with a commercial computer system that is validated, but no longer supported by the vendor that sold the system to the hospital? ADDENDA June 6 & 7 |
| May 23, 2006 |
Is ABO, Rh and/or K typing routinely performed by phenotyping or genotyping by the UK National Blood Service? ADDENDA May 31 |
| May 23, 2006 |
What incentives do hospital-based blood donor center programs use to encourage donations, and how are these incentives obtained? ADDENDA May 25 |
| May 23, 2006 |
Experience in the use of pressure pumps or other rapid infusion techniques for red cell administration ADDENDA June 5 |
| May 21, 2006 |
What methods are used to measure the pH of donor platelets when doing routine QC activity required by the 23rd edition of AABB Standards (5.7.5.16 and 5.7.5.19)? ADDENDA May 29, 2006 |
| May 12, 2006 |
Management of a potential PBSC transplant recipient with multiple red cell antibodies |
| May 12, 2006 |
REACTIVATED DISCUSSION: Monitoring temperature of blood products transported within the hospital Sept. 12, 2002; ADDENDA Sept. 14, 16 & 18, 2002; May 12, 22 & 24, 2006; Feb. 6, 2007 |
| May 12, 2006 |
Is it considered acceptable to use a patient's historical ABO/Rh result from a previous visit when filling an order for FFP? |
| May 4, 2006 |
What INR thresholds are being used for prophylactic and therapeutic use of FFP? ADDENDA May 7, 8, 15 & 23; July 2 |
| May 4, 2006 |
Freezing units of autologous red blood cells to prevent the units from expiring, if surgery is postponed ADDENDA May 8 & 17 |
| May 4, 2006 |
How is a phlebotomist positively identified, so that a transfusion service knows who collected a sample for pre-transfusion compatibility testing? ADDENDA May 7 & 17 |
| May 3, 2006 |
Management of pregnancies that are complicated by non-D alloantibodies that have clinically-significant specificities ADDENDA May 4, 8 & 17; Aug. 15 |
| Apr. 26, 2006 |
Strategies on timing of irradiation of platelet products ADDENDA Apr. 27, 2006 |
| April 25, 2006 |
Is there evidence that girls and premenopausal women who need transfusion should receive donor RBC units that are phenotype tested and matched for CDE and K antigens, to reduce risk of alloimmunization and prevent future cases of hemolytic disease of the newborn? ADDENDA May 8 & 12 |
| Apr. 23, 2006 |
Practices regarding selection of CMV seronegative and/or leukocyte reduced blood products for transfusion of pregnant patients ADDENDA Apr. 24 & 26 |
| Apr. 21, 2006 |
Should pregnant women who need transfusion receive irradiated blood products to prevent Graft versus Host Disease? ADDENDA Apr. 23, 25 & 26 |
| Apr. 21, 2006 |
Is it clinically useful to differentiate between various subgroups of A, such as A2, A3, and others, in the setting of renal transplantation? ADDENDA Aug. 3 & 9 |
| Apr. 16, 2006 |
How often should a blood donation be mixed while it is being collected? ADDENDA Apr. 21, 2006 |
| Apr. 8, 2006 |
REACTIVATED DISCUSSION: 2,3-DPG kits and reagents needed for red cell storage studies Dec. 4, 2002; ADDENDA Dec. 11, 2002; Jan. 9, 17, 21 & 27; Feb. 5 & May 6, 2003; Apr. 8, 2006 |
| Apr. 4, 2006 |
REACTIVATED DISCUSSION: Use of phenotype-matched donor RBCs for transfusion of patients with sickle cell anemia Oct. 22, 2001; ADDENDA Oct. 24 & 29, 2001; Feb 6, 2005; Apr. 4, 2006 |
| Apr. 4, 2006 |
Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS) |
| Mar. 31, 2006 |
Has any hospital implemented a blood management program that is directed by the same physician who provides the medical direction of the transfusion medicine service and the medical direction of the blood management program? ADDENDA Apr. 4 & 9 |
| Mar. 30, 2006 |
Do transfusion service laboratories use a 'control' to check for spontaneous agglutination to rule out possible false positive results when performing a direct antiglobulin test (DAT) by GEL Test Technology? ADDENDA Apr. 6 |
| Mar. 29, 2006 |
Compliance
with the new requirements for labeling of aliquots
and pooled components Mar.
29; ADDENDA Apr. 7 & 21; June 12;
Aug. 9; Nov. 12; Dec 27, 2007 |
| Mar. 28, 2006 |
REACTIVATED DISCUSSION: Policies
defining when platelets and RBCs should
be cultured as part of a transfusion reaction investigation Oct.
4, 2001; ADDENDA Oct 6 & 8, 2001; Mar.
28, 2006; June 26, July 2 & 16, 2007 |
| Mar. 28, 2006 |
Is
it necessary to determine the specificity of
HTLA antibodies? ADDENDA Mar.
29 & 31; Sept. 17 & 20, 2007 |
| Mar. 23, 2006 |
Do any physicians issue a bill for the medical evaluation of patients who request autologous blood collection services? ADDENDA Mar. 31 |
| Mar. 18, 2006 |
Are there compelling reasons to utilize a three-bed mini-coach rather than a full size coach for mobile blood collection operations? ADDENDA Mar. 19 & 31 |
| Mar. 13, 2006 |
What offers greater patient safety, a dedicated blood administration team or extensive education of nurses who might transfuse blood and components? |
| Mar. 10, 2006 |
Detection of transfusion reactions that are not reported to the blood bank or transfusion service ADDENDA Mar. 14 |
| Mar. 10, 2006 |
A question regarding methods for detecting platelet antibodies and how to report discordant test results |
| Mar. 3, 2006 |
What is a minimum change in blood pressure that will trigger a transfusion reaction work up? ADDENDA Mar. 10, 12 & 14 |
| Mar. 2, 2006 |
REACTIVATED DISCUSSION: What is an appropriate way for institutions to assure patient identification? April 8, 2002; ADDENDA April 11, 2002; Feb. 24 & 25, Mar. 2 & 5, 2006 |
| Feb. 26, 2006 |
Is there concern by transfusion medicine specialists that new guidelines for platelet donations may impact on the availability of platelets for transfusion? ADDENDA Feb. 27 & Mar. 1, 5 & 8 |
| Feb. 25, 2006 |
Experience in the US with the use of bacterial detection systems cleared by the FDA to allow the use of platelet products for up to seven days |
| Feb. 20, 2006 |
Should a blood donor who has had a repeat reactive test result for anti-HTLV I/II with an indeterminate Western Blot in 2002 be allowed to donate blood in 2006, given that they have had repeated follow up tests for anti-HTLV I/II, and provided the individual in question is otherwise qualified to donate and currently tests negative by all required donor screening tests? ADDENDA Feb. 21 & 23 |
| Feb. 13, 2006 |
Should a prospective blood donor be deferred merely because they have had sexual contact with an individual who had a reactive HIV 1/2 antibody screening test followed by a negative or indeterminate Western Blot plus a negative HIV-1 NAT? ADDENDA Feb. 14 & 15 |
| Feb. 10, 2006 |
Are ABO isoagglutinin titers performed to measure IgM antibodies, IgG antibodies, or both? ADDENDA Feb. 13, 14, 20 & 25 |
| Feb. 10, 2006 |
Does your emergency/disaster plan include a reliable way to contact amateur radio operators, in the event that emergency amateur radio communications are required? ADDENDA Feb. 25, Mar. 12, 14, 23, 25 & 29 |
| Feb. 7, 2006 |
How much pretransfusion testing should be done for a patient with anti-D, acquired by having received an injection of RhIG? ADDENDA Feb. 27 & Mar. 12 |
| Feb. 7, 2006 |
Are colleagues modifying their practice over concerns about the risk associated with aprotinin in cardiac surgery? |
| Jan. 30, 2006 |
Should a hospital dispense Rh Immune Globulin (RhIG) for a patient, in the absence of a current Rh determination on the patient? ADDENDA Feb. 7 & 15 |
| Jan. 24, 2006 |
REACTIVATED DISCUSSION: Reimbursement for the computer crossmatch procedure - revisited. Aug. 29, 2002; ADDENDA Apr. 20, 22, 25; Nov. 17 & 21, 2005; Jan. 24 & Feb. 13, 2006 |
| Jan. 22, 2006 |
Is it possible to incorporate a transfusion service laboratory into a core laboratory? ADDENDA Mar. 13, 15 & 23 |
| Jan. 22, 2006 |
A Tissue License is required in California for the storage of "mother's milk" ADDENDA Jan. 25, Mar. 12, Apr. 11; May 12 & 13; Oct. 1 |
| Jan. 21, 2006 |
Behavior-Based Blood Donor Deferrals in the Era of Nucleic Acid Testing ADDENDA Apr. 3 |
| Jan. 18, 2006 |
Suggestions for the reporting of sensitive genetic test results ADDENDA Jan. 19, 20 & 21; Feb. 8 |
| Jan. 8, 2006 |
REACTIVATED DISCUSSION: Improving the process of patient identification - 2003 update Dec. 30, 2002; ADDENDA Jan. 8, 2006 |
| Jan. 8, 2006 |
REACTIVATED DISCUSSION: What is the status of automated pre-transfusion compatibility testing in the USA? July 13, 2001; ADDENDA July 14, 2001; Jan. 8, 10, 19 & 25, 2006 |
| Jan. 8, 2006 |
Is anyone using an intravenous Rh immune globulin preparation for the treatment of ITP that has not been approved by the FDA for that indication? ADDENDA Jan. 10, 11 & 13, 2006 |
| Jan. 7, 2006 |
What
US States have requirements similar to the California
Paul Gann Blood Safety Act? ADDENDA Jan.
21; Jan. 30, 2008 |
| Jan. 5, 2006 |
REACTIVATED DISCUSSION: Emergency reversal of Warfarin effect - FFP or Prothrombin Complex Concentrate? May 30, 2002; ADDENDA May 31, 2002; Jan. 5, 6, 8, 9, 10, 13, 15, 17 & 24, 2006 |
| Jan. 2, 2006 |
REACTIVATED DISCUSSION: Does your hospital have a problem with STAT pre-transfusion testing orders for elective scheduled surgery? April 12, 2002; ADDENDA April 13 & 16, Dec. 30 & 31, 2005; Jan. 2, 5 & 8, 2006 |
